Zydus Cadila gets USFDA nod to market Mesalamine suppositories

Zydus Cadila gets USFDA nod to market Mesalamine suppositories "Zydus Cadila has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use...1000 mg," the drug firm said in a regulatory filing.

No comments:

Post a Comment